Get started
AAA

ARTERRA BIOSCIENCE

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

ARBS chart


Full chart

Key stats


Market capitalization
‪12.52 M‬ EUR
Dividend yield (indicated)
5.32%
Price to earnings Ratio (TTM)
9.55
Basic EPS (TTM)
0.20 EUR
Net income (FY)
‪1.08 M‬ EUR
Revenue (FY)
‪3.30 M‬ EUR
Shares float
‪2.08 M‬
Beta (1Y)
0.35

About ARTERRA BIOSCIENCE


Sector
Health Technology
Industry
Biotechnology
CEO
Maria Gabriella Colucci
Website
arterrabio.it
Headquarters
Naples
Founded
2003
ISIN
IT0005386369
FIGI
BBG00QJCSCL5
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. Its main activities include the development of technological platforms in the screening of active compounds for different industrial applications; setting up of new extraction processes to improve the sustainability and yield of interesting compounds; and the production of raw materials for various industrial applications such as agriculture, cosmetics, and nutraceuticals. The company was founded by Maria Gabriella Colucci and Fabio Apone on October 28, 2003 and is headquartered in Naples, Italy.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ARBS news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARBS is 1.88 EUR — it has decreased by −2.59% in the past 24 hours. Watch ARTERRA BIOSCIENCE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ARTERRA BIOSCIENCE stocks are traded under the ticker ARBS.
ARBS stock has fallen by −6.00% compared to the previous week, the month change is a −3.09% fall, over the last year ARTERRA BIOSCIENCE has showed a 20.51% increase.
We've gathered analysts' opinions on ARTERRA BIOSCIENCE future price: according to them, ARBS price has a max estimate of 3.20 EUR and a min estimate of 3.20 EUR. Watch ARBS chart and read a more detailed ARTERRA BIOSCIENCE stock forecast: see what analysts think of ARTERRA BIOSCIENCE and suggest that you do with its stocks.
ARBS reached its all-time high on Nov 21, 2019 with the price of 5.34 EUR, and its all-time low was 1.48 EUR and was reached on Nov 16, 2023. View more price dynamics on ARBS chart.
See other stocks reaching their highest and lowest prices.
ARBS stock is 2.66% volatile and has beta coefficient of 0.35. Track ARTERRA BIOSCIENCE stock price on the chart and check out the list of the most volatile stocks — is ARTERRA BIOSCIENCE there?
Yes, you can track ARTERRA BIOSCIENCE financials in yearly and quarterly reports right on TradingView.
ARBS net income for the last half-year is ‪517.26 K‬ EUR, while the previous report showed ‪827.54 K‬ EUR of net income which accounts for −37.49% change. Track more ARTERRA BIOSCIENCE financial stats to get the full picture.
Yes, ARBS dividends are paid annually. The last dividend per share was 0.10 EUR. As of today, Dividend Yield (TTM)% is 5.44%. Tracking ARTERRA BIOSCIENCE dividends might help you take more informed decisions.
ARTERRA BIOSCIENCE dividend yield was 6.16% in 2023, and payout ratio reached 63.25%. The year before the numbers were 4.63% and 47.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARTERRA BIOSCIENCE EBITDA is ‪646.04 K‬ EUR, and current EBITDA margin is 5.32%. See more stats in ARTERRA BIOSCIENCE financial statements.
Like other stocks, ARBS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARTERRA BIOSCIENCE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARTERRA BIOSCIENCE technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARTERRA BIOSCIENCE stock shows the sell signal. See more of ARTERRA BIOSCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.